Coronavirus Disease 2019 (COVID-19) Pandemic on the Oral Hygiene Status of Children
Launched by GAZI UNIVERSITY · May 28, 2024
Trial Information
Current as of February 19, 2025
Completed
Keywords
ClinConnect Summary
Study Rationale and Objectives:
The primary motivation behind this study lies in understanding the impact of the COVID-19 pandemic on oral health behaviors, specifically focusing on children at high risk for dental caries.
Objectives include assessing changes in tooth brushing habits and dietary patterns among both children and their parents.
Study Design:
The study employs a prospective observational design. Participants are parents of 155 children aged 3-5 years. Data collection occurs at two time points: before and after the COVID-19 pandemic.
Data Collection Instruments:
A structu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 3-5 year old children with high caries risk. To identify high caries-risk children, the criteria used by the the American Academy of Pediatric Dentistry (AAPD) for assessing a child's dental caries risk were applied.
- Exclusion Criteria:
- • Childrens with systemic health problems and childrens with any space maintainers.
Trial Officials
ZELIHA HATİPOĞLU PALAZ
Principal Investigator
Gazi University
NAGEHAN AKTAŞ
Principal Investigator
Gazi University
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Biskek Street/ Emek, Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0